Investor
ENAVATE SCIENCES GP, LLC
CIK 0001953107 · filed 2026-05-15 · SEC filing
13F book
$351.5M
Positions
7
Largest name
28.3%
Sionna Therapeutics, Inc. · SION
Est. mark
−$125.3M
Price effect on 7 names still held. Flow −$30M.
| Name | Ticker | Shares | Value | Weight | Est. mark | Change |
|---|---|---|---|---|---|---|
| Sionna Therapeutics, Inc. | SION | 2.48M | $99.3M | 28.3% | −$2.6M | Held |
| Immunome Inc. | IMNM | 3.61M | $79M | 22.5% | $1.41M | Cut−$23.4M |
| Zenas BioPharma, Inc. | ZBIO | 3.92M | $76.6M | 21.8% | −$65.7M | Held |
| Compass Therapeutics, Inc. | CMPX | 7.79M | $41.2M | 11.7% | −$623.1K | Held |
| Bridgebio Oncology Therapeut | — | 2.63M | $23.5M | 6.7% | −$9.38M | Held |
| Upstream Bio, Inc. | UPB | 2.46M | $22.1M | 6.3% | −$44.6M | Held |
| Camp4 Therapeutics Corp | CAMP | 2.19M | $9.66M | 2.7% | −$3.77M | Cut−$8.95M |
Positions as of Q1 2026. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.